(Q27674725)
Statements
Erlotinib binds both inactive and active conformations of the EGFR tyrosine kinase domain (English)
0 references
15 December 2012
0 references
448
0 references
3
0 references
417-23
0 references
25 July 2019
1 reference
2 references
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference